机构:[1]Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.[2]Department of Femoral Head, Linyi People's Hospital, The Intersection of Wuhan Road and Wohushan Road, Linyi, 276000, Shandong, China.
第一作者机构:[1]Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.[2]Department of Femoral Head, Linyi People's Hospital, The Intersection of Wuhan Road and Wohushan Road, Linyi, 276000, Shandong, China.
通讯作者:
推荐引用方式(GB/T 7714):
Li Bin,Zhan Huixian,Luo Jintao,et al.A novel serological biomarker are associated with disease severity in patients with osteoarthritis[J].Journal of bone and mineral metabolism.2022,doi:10.1007/s00774-022-01364-0.
APA:
Li Bin,Zhan Huixian,Luo Jintao,Wang Xuewen,Cao Ting&Wei Biaofang.(2022).A novel serological biomarker are associated with disease severity in patients with osteoarthritis.Journal of bone and mineral metabolism,,
MLA:
Li Bin,et al."A novel serological biomarker are associated with disease severity in patients with osteoarthritis".Journal of bone and mineral metabolism .(2022)